6.20
-0.07 (-1.12%)
-0.07 (-1.12%)
Upgrade to Real-Time
Premarket
| Volume | 500 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| F star Therapeutics Inc | FSTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.07 | -1.12% | 6.20 | 07:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.27 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1 | 500 | - | 2.07 - 9.30 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:29:10 | formt | 500 | $ 6.20 | USD |
Period:
Draw Mode:
F star Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 133.83M | 21.58M | 21.35M | $ 21.17M | $ - | -2.04 | -4.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 2.40% |
F star Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FSTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.61 | 6.66 | 3.56 | 6.24 | 2,124,558 | 2.59 | 71.75% |
| 1 Month | 3.04 | 6.66 | 2.75 | 5.73 | 685,611 | 3.16 | 103.95% |
| 3 Months | 3.58 | 6.66 | 2.07 | 4.94 | 311,033 | 2.62 | 73.18% |
| 6 Months | 5.00 | 6.66 | 2.07 | 4.58 | 213,222 | 1.20 | 24.0% |
| 1 Year | 8.92 | 9.30 | 2.07 | 5.44 | 204,785 | -2.72 | -30.49% |
| 3 Years | 3.90 | 15.50 | 2.07 | 6.43 | 183,778 | 2.30 | 58.97% |
| 5 Years | 3.90 | 15.50 | 2.07 | 6.43 | 183,778 | 2.30 | 58.97% |
F star Therapeutics Description
| F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than immuno-oncology treatments. |